Where does CymaBay Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), CymaBay Therapeutics, Inc. ranks #8,362 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does CymaBay Therapeutics, Inc. hold?

CymaBay Therapeutics, Inc. holds 38 US utility patents granted between 2015 and 2023, spanning 5 technology areas.

What is CymaBay Therapeutics, Inc.'s Innovation Score?

CymaBay Therapeutics, Inc. has an Innovation Score of 29.9 out of 100 (32nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does CymaBay Therapeutics, Inc. focus on?

CymaBay Therapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 37 patents, ranking #584 of 7,163 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is CymaBay Therapeutics, Inc.'s patent grant rate increasing or decreasing?

CymaBay Therapeutics, Inc.'s recent grant velocity is -64% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for CymaBay Therapeutics, Inc.'s patents?

CymaBay Therapeutics, Inc.'s patents average 13.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the CymaBay Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

CymaBay Therapeutics, Inc.

USPTO PatentsView assignee record - 38 granted patents across 5 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cymabay ranks #8,362 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 5 technology areas.

#8,362
of 49,997 US assignees by volume: 32nd percentile
by Innovation Score (29.9/100): 13.1
avg claims per patent: -64%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8362 · US Corporation #8,362 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 38 grants
UPPER-Q #8,362/49,997
PHOTO-FINISH Concaten
CPC-NARROW A61K · 5 areas
INNOV-THIN 29.9/100
CLAIMS-RICH 13.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -64% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Concaten, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cymabay’s 29.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (42%) Velocity 1.4 pts (5%) Breadth 7.9 pts (26%) Claim depth 7.9 pts (26%)

Qualcomm Incorporated · highest

85
Piramal Imaging · near

30
CymaBay Therapeutics · this assignee

30
Infrastructure… · near

30
Tempur-Pedic… · near

30
Batesville Services · near

30
3D Lighting… · lowest

7

What this shows Cymabay's Innovation Score is 29.9/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cymabay?

Each dot is one of Cymabay’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cymabay’s own 13.1 claims/patent is ABOVE the 11.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cymabay vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cymabay's grants concentrate

CymaBay Therapeutics, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 97.4% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (7 grants) versus a trough of 1 in 2023. By volume, Cymabay sits between Concaten, Inc. and Datacolor, Inc..

Cymabay's three-year grant acceleration

CymaBay Therapeutics, Inc. shows 3 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Concaten

38
Cool Planet Energ…

38
Corn Bak B V

38
Cruiser Accessori…

38
Delta Tooling

38
Dnae Group Holdin…

38
Dongguan Huihuan…

38
Datacolor

38
Cymabay Therapeut… ◀

38

What this shows CymaBay holds 38 patents at rank #8,362, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CymaBay

By rank, the assignees closest to #8,362 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in CymaBay's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for CymaBay, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), CymaBay ranks #584 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (30 here).

Tempur-Pedic Management, LLC 30 Infrastructure Renewal Institute of Southern China 30 Batesville Services, Inc. 30 Piramal Imaging SA 30

Cymabay's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 32nd percentile higher than 32% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

CymaBay Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	13.2%
2016	6	15.8%
2017	6	15.8%
2018	4	10.5%
2019	7	18.4%
2020	4	10.5%
2021	3	7.9%
2022	2	5.3%
2023	1	2.6%

Which technologies does CymaBay Therapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 37

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 32

C07D - Heterocyclic Compounds 7

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 4

C07C - Acyclic OR Carbocyclic Compounds 4

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

CymaBay Therapeutics, Inc.'s patent record in context - here's where to go next.

CymaBay Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 97.4% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #8,362 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare CymaBay Therapeutics, Inc. against Concaten, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.